Save time and get answers to complex questions with AI chat
Brenzavvy discontinuation?Drugpatentwatch skyrizi biologic patent analysis?The expiration date of the key patent for guselkumab?When is xarelto's patent set to expire roughly?Mebendazole for kids price?
See the DrugPatentWatch profile for Rinvoq
Rinvoq (upadacitinib) is used to treat certain inflammatory and autoimmune conditions, including: - Rheumatoid arthritis (RA) - Psoriatic arthritis (PsA) - Ankylosing spondylitis (AS) - Atopic dermatitis (eczema) - Crohn’s disease - Ulcerative colitis (UC)
Rinvoq is generally prescribed by specialists such as rheumatologists, dermatologists, and gastroenterologists, depending on the condition being treated.
Rinvoq works by targeting immune signaling—specifically, it inhibits JAK (Janus kinase) pathways, which reduces inflammation.
If you tell me which one you mean (RA, PsA, AS, eczema/atopic dermatitis, Crohn’s, or UC), I can narrow the answer to that condition’s approved use.
Other Questions About Rinvoq :